Literature DB >> 17998011

C-reactive protein, metabolic syndrome, and end organ damage.

Hwee Teoh, Subodh Verma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17998011     DOI： 10.1016/j.metabol.2007.07.002

Source DB:  PubMed          Journal:  Metabolism        ISSN： 0026-0495            Impact factor:   8.694


× No keyword cloud information.
  4 in total

1.  Metabolic syndrome does not impair the response to alfuzosin treatment in men with lower urinary tract symptoms: a double-blind, randomized, placebo-controlled study.

Authors:  Selçuk Altın; Tunç Ozan; Selçuk İlhan; Nevin İlhan; Rahmi Onur
Journal:  Turk J Urol       Date:  2015-09

Review 2.  Lower urinary-tract symptoms and testosterone in elderly men.

Authors:  Aksam A Yassin; Ahmed I El-Sakka; Farid Saad; Louis J G Gooren
Journal:  World J Urol       Date:  2008-07-02       Impact factor: 4.226

Review 3.  Effects of testosterone on the lower urinary tract go beyond the prostate: New insights, new treatment options.

Authors:  Farid Saad; Aksam A Yassin; Ahmad Haider; Louis Gooren
Journal:  Arab J Urol       Date:  2011-09-09

Review 4.  Impact of Testosterone Deficiency and Testosterone Therapy on Lower Urinary Tract Symptoms in Men with Metabolic Syndrome.

Authors:  Abdulmaged M Traish; Vanessa Johansen
Journal:  World J Mens Health       Date:  2018-07-03       Impact factor: 5.400
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.